دورية أكاديمية
Characteristics and outcomes of patients presenting with acute myocardial infarction and cardiogenic shock during COVID-19.
العنوان: | Characteristics and outcomes of patients presenting with acute myocardial infarction and cardiogenic shock during COVID-19. |
---|---|
المؤلفون: | Ahlers MJ; Department of Medicine, Ronald Reagan-UCLA Medical Center, Los Angeles, California, USA., Srivastava PK; Division of Cardiology, Ronald Reagan-UCLA Medical Center, Los Angeles, California, USA., Basir MB; Division of Cardiology, Henry Ford Hospital/Wayne State University, Detroit, Michigan, USA., O'Neill WW; Division of Cardiology, Henry Ford Hospital/Wayne State University, Detroit, Michigan, USA., Hacala M; Division of Cardiology, Henry Ford Hospital/Wayne State University, Detroit, Michigan, USA., Ammar K; Division of Undergraduate Studies, University of California, Berkeley, California, USA., Khalil S; Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan-UCLA Medical Center, Los Angeles, California, USA., Hollowed J; Division of Cardiology, Ronald Reagan-UCLA Medical Center, Los Angeles, California, USA., Nsair A; Division of Cardiology, Ronald Reagan-UCLA Medical Center, Los Angeles, California, USA.; Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan-UCLA Medical Center, Los Angeles, California, USA. |
المصدر: | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2022 Oct; Vol. 100 (4), pp. 568-574. Date of Electronic Publication: 2022 Sep 07. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 100884139 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-726X (Electronic) Linking ISSN: 15221946 NLM ISO Abbreviation: Catheter Cardiovasc Interv Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: New York, NY : Wiley-Liss, c1999- |
مواضيع طبية MeSH: | COVID-19*/complications , Heart-Assist Devices*/adverse effects , Myocardial Infarction*/diagnosis , Myocardial Infarction*/etiology , Myocardial Infarction*/therapy , Percutaneous Coronary Intervention*/adverse effects , ST Elevation Myocardial Infarction*/diagnosis , ST Elevation Myocardial Infarction*/etiology , ST Elevation Myocardial Infarction*/therapy, Female ; Humans ; Middle Aged ; Pandemics ; Shock, Cardiogenic/diagnosis ; Shock, Cardiogenic/etiology ; Shock, Cardiogenic/therapy ; Treatment Outcome ; United States/epidemiology |
مستخلص: | Objectives: To evaluate characteristics and outcomes of patients presenting with acute myocardial infarction and cardiogenic shock (AMICS) during the coronavirus disease 2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has created challenges in delivering acute cardiovascular care. Quality measures and outcomes of patients presenting with AMICS during COVID-19 in the United States have not been well described. Methods: We identified 406 patients from the National Cardiogenic Shock Initiative (NCSI) with AMICS and divided them into those presenting before (N = 346, 5/9/2016-2/29/2020) and those presenting during the COVID-19 pandemic (N = 60, 3/1/2020-11/10/2020). We compared baseline clinical data, admission characteristics, and outcomes. Results: The median age of the cohort was 64 years, and 23.7% of the group was female. There were no significant differences in age, sex, and medical comorbidities between the two groups. Patients presenting during the pandemic were less likely to be Black compared to those presenting prior. Median door to balloon (90 vs. 88 min, p = 0.38), door to support (88 vs. 78 min, p = 0.13), and the onset of shock to support (74 vs. 62 min, p = 0.15) times were not significantly different between the two groups. Patients presented with ST-elevation myocardial infarction more often during the COVID-19 period (95.0% vs. 80.0%, p = 0.005). In adjusted logistic regression models, COVID-19 period did not significantly associate with survival to discharge (odds ratio [OR] 1.09, 95% confidence interval [CI] 0.54-2.19, p = 0.81) or with 1-month survival (OR 0.82, 95% CI 0.42-1.61, p = 0.56). Conclusions: Care of patients presenting with AMICS has remained robust among hospitals participating in the NCSI during the COVID-19 pandemic. (© 2022 Wiley Periodicals LLC.) |
References: | J Am Coll Cardiol. 2020 Jul 21;76(3):280-288. (PMID: 32470516) N Engl J Med. 2020 Jul 2;383(1):88-89. (PMID: 32343497) Stroke. 2021 May;52(5):1826-1829. (PMID: 33728926) Eur Heart J Qual Care Clin Outcomes. 2020 Jul 1;6(3):210-216. (PMID: 32467968) Am J Cardiol. 2017 Mar 15;119(6):845-851. (PMID: 28040188) Am Heart J. 2020 Aug;226:147-151. (PMID: 32569892) Heart. 2020 Dec;106(23):1805-1811. (PMID: 32868280) J Cardiovasc Pharmacol. 2020 Nov;76(5):540-548. (PMID: 33170591) Lancet Infect Dis. 2020 May;20(5):533-534. (PMID: 32087114) Circulation. 2015 Sep 29;132(13):1243-51. (PMID: 26286905) Eur Heart J Qual Care Clin Outcomes. 2021 May 3;7(3):238-246. (PMID: 32730620) Lancet Public Health. 2020 Oct;5(10):e536-e542. (PMID: 32950075) J Am Coll Cardiol. 2020 Sep 15;76(11):1318-1324. (PMID: 32828614) Circulation. 2003 Jun 24;107(24):2998-3002. (PMID: 12821585) J Am Coll Cardiol. 2021 Jan 19;77(2):227-228. (PMID: 33446315) Nurs Clin North Am. 2015 Dec;50(4):735-47. (PMID: 26596661) Circ Cardiovasc Interv. 2020 Aug;13(8):e009413. (PMID: 32791953) Int J Cardiol Heart Vasc. 2020 Dec;31:100659. (PMID: 33072848) JAMA Surg. 2017 Mar 1;152(3):292-298. (PMID: 28097305) N Engl J Med. 1999 Aug 26;341(9):625-34. (PMID: 10460813) Catheter Cardiovasc Interv. 2022 Oct;100(4):568-574. (PMID: 36073018) MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257. (PMID: 32915166) ESC Heart Fail. 2021 Feb;8(1):333-343. (PMID: 33283476) Curr Opin Anaesthesiol. 2019 Jun;32(3):278-284. (PMID: 31045634) Crit Care Med. 2004 Mar;32(3):858-73. (PMID: 15090974) Lancet. 2020 Aug 8;396(10248):381-389. (PMID: 32679111) JAMA Cardiol. 2020 Dec 1;5(12):1419-1424. (PMID: 32766756) Am J Cardiol. 2021 Mar 1;142:25-34. (PMID: 33301770) Eur Heart J. 2020 Jun 7;41(22):2083-2088. (PMID: 32412631) |
فهرسة مساهمة: | Keywords: acute myocardial infarction/STEMI; coronary artery disease, intervention; mechanical circulatory support, ECMO/IABP/tandem/Impella; shock, cardiogenic |
تواريخ الأحداث: | Date Created: 20220908 Date Completed: 20221012 Latest Revision: 20221013 |
رمز التحديث: | 20240628 |
مُعرف محوري في PubMed: | PMC9539126 |
DOI: | 10.1002/ccd.30390 |
PMID: | 36073018 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1522-726X |
---|---|
DOI: | 10.1002/ccd.30390 |